GeoVax Congratulates Don Diamond, Ph.D. as Finalist for Vaccine Industry Excellence Award at World Vaccine Congress
15 mars 2023 09h00 HE
|
GeoVax, Inc.
Dr. Diamond and City of Hope COVID-19 Vaccine Team Nominated forBest Academic/Research Team Award ATLANTA, GA, March 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq:...
GeoVax and EmVenio Announce Collaboration to Expand Phase 2 COVID-19 Booster Vaccine Clinical Trial
15 févr. 2023 09h00 HE
|
GeoVax, Inc.
Mobile Community Clinical Research Facility to be Deployed in California ATLANTA, GA, Feb. 15, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc. (Nasdaq: GOVX), a biotechnology...
POP Biotechnologies' SNAP Vaccine System Safe and Effective in a Phase II Clinical Trial for COVID-19
30 nov. 2022 15h01 HE
|
POP Biotechnologies
BUFFALO, N.Y., Nov. 30, 2022 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a Buffalo, New York-based biopharmaceutical startup, announces the publication of an interim analysis of the Phase 2...
GeoVax to Present at Vaccines Summit-2022
11 oct. 2022 09h00 HE
|
GeoVax, Inc.
Presentation to Focus on Development of Pan-Coronavirus (Universal) Vaccines to Protect Against Evolving Variants ATLANTA, GA, Oct. 11, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs, Inc....
POP Biotechnologies' SNAP Vaccine Platform Enters Large-Scale Phase III Clinical Trials for COVID-19
20 sept. 2022 21h31 HE
|
POP Biotechnologies, Inc.
BUFFALO, N.Y., Sept. 20, 2022 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a Buffalo, New York-based biopharmaceutical startup, announces the commencement of two Phase 3 clinical studies of...
Diaper banks, We Can Do This campaign team to protect kids as young as 6 months from COVID-19
06 juil. 2022 13h34 HE
|
National Diaper Bank Network
New Haven, July 06, 2022 (GLOBE NEWSWIRE) -- U.S. Department of Health and Human Services (HHS) Secretary Xavier Becerra; Rep. Rosa DeLauro, who represents Connecticut’s 3rd Congressional District;...
GeoVax to Present COVID-19 Vaccine Data at the Vaccine Summit Boston 2022
21 mars 2022 09h00 HE
|
GeoVax, Inc.
Presentation to Focus on GEO-CM02 Being Developed as aUniversal Vaccine to Address Evolving SARS-CoV-2 Variants ATLANTA, GA, March 21, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – GeoVax Labs,...
GeoVax Retains CATO SMS to Manage Two Phase 2 COVID-19 Vaccine Clinical Trials
14 mars 2022 09h00 HE
|
GeoVax, Inc.
Comparative Trial Against Pfizer/BioNTech Vaccine Among Immunocompromised PatientsBooster to Pfizer/BioNTech or Moderna Vaccines Among Healthy PatientsATLANTA, GA, March 14, 2022 (GLOBE NEWSWIRE) --...
POP Biotechnologies Vaccine Technology to Enter Phase III Clinical Studies as Part of Eubiologics' COVID-19 Vaccine Candidate, EuCorVac-19
06 févr. 2022 22h18 HE
|
POP Biotechnologies, Inc.
BUFFALO, N.Y., Feb. 06, 2022 (GLOBE NEWSWIRE) -- POP Biotechnologies (POP BIO), a biopharmaceutical startup, announces the approval of the plan for a Phase 3 clinical study of EuCorVac-19, a...
Fifth Update of ACR COVID-19 Vaccine Guidance Supports Fourth Doses for High-Risk Rheumatic Disease Patients
02 févr. 2022 10h49 HE
|
American College of Rheumatology
Atlanta, Feb. 02, 2022 (GLOBE NEWSWIRE) -- The American College of Rheumatology has issued an updated version of its COVID-19 Vaccine Clinical Guidance for Patients with Rheumatic and...